Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Lynch

Showing results (81-90 of 133) with videos related to

Pageof 14
Sort By:
Journal of Alzheimer'S Disease : JAD|April 21, 2020
Structural Brain Changes in Pre-Clinical FTD MAPT Mutation CarriersClara Domínguez-Vivero, Liwen Wu, Seonjoo Lee, et al.
Parkinsonism & Related Disorders|August 17, 2005
Clinical traits of LRRK2-associated Parkinson's disease in Ireland: a link between familial and idiopathic PDDavid Gosal, Owen A Ross, Joe Wiley, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 27, 2025
Transforming Care Across Countries: Lessons from the Integrated Care Networks for Parkinson's Disease Study (iCARE-PD)Deepa Dash, Margherita Fabbri, Joseph Saade, et al.
Parkinsonism & Related Disorders|October 29, 2020
The "round the houses" sign and "zig-zag" sign in progressive supranuclear palsy and other conditionsConor Fearon, Robert Field, Eoghan Donlon, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 22, 2018
Psychiatric symptoms in preclinical behavioural-variant frontotemporal dementia in <i>MAPT</i> mutation carriersGayathri Cheran, Hannah Silverman, Masood Manoochehri, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 12, 2007
Pathogenicity of the Lrrk2 R1514Q substitution in Parkinson's diseaseMathias Toft, Ignacio F Mata, Owen A Ross, et al.
JAMA Neurology|March 6, 2013
Parkin disease: a clinicopathologic entity?Karen M Doherty, Laura Silveira-Moriyama, Laura Parkkinen, et al.
Molecular Brain|November 29, 2013
Exosomes neutralize synaptic-plasticity-disrupting activity of Aβ assemblies in vivoKyongman An, Igor Klyubin, Youngkyu Kim, et al.
Neuroscience Letters|May 12, 2009
Phactr2 and Parkinson's diseaseChristian Wider, Sarah J Lincoln, Michael G Heckman, et al.
American Journal of Neurodegenerative Disease|December 10, 2013
GWAS risk factors in Parkinson's disease: LRRK2 coding variation and genetic interaction with PARK16Alexandra I Soto-Ortolaza, Michael G Heckman, Catherine Labbé, et al.
Pageof 14

Showing results (81-90 of 133) with videos related to

Sort By:
Pageof 14
Journal of Alzheimer'S Disease : JAD|April 21, 2020
Structural Brain Changes in Pre-Clinical FTD MAPT Mutation CarriersClara Domínguez-Vivero, Liwen Wu, Seonjoo Lee, et al.
Parkinsonism & Related Disorders|August 17, 2005
Clinical traits of LRRK2-associated Parkinson's disease in Ireland: a link between familial and idiopathic PDDavid Gosal, Owen A Ross, Joe Wiley, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 27, 2025
Transforming Care Across Countries: Lessons from the Integrated Care Networks for Parkinson's Disease Study (iCARE-PD)Deepa Dash, Margherita Fabbri, Joseph Saade, et al.
Parkinsonism & Related Disorders|October 29, 2020
The "round the houses" sign and "zig-zag" sign in progressive supranuclear palsy and other conditionsConor Fearon, Robert Field, Eoghan Donlon, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 22, 2018
Psychiatric symptoms in preclinical behavioural-variant frontotemporal dementia in <i>MAPT</i> mutation carriersGayathri Cheran, Hannah Silverman, Masood Manoochehri, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 12, 2007
Pathogenicity of the Lrrk2 R1514Q substitution in Parkinson's diseaseMathias Toft, Ignacio F Mata, Owen A Ross, et al.
JAMA Neurology|March 6, 2013
Parkin disease: a clinicopathologic entity?Karen M Doherty, Laura Silveira-Moriyama, Laura Parkkinen, et al.
Molecular Brain|November 29, 2013
Exosomes neutralize synaptic-plasticity-disrupting activity of Aβ assemblies in vivoKyongman An, Igor Klyubin, Youngkyu Kim, et al.
Neuroscience Letters|May 12, 2009
Phactr2 and Parkinson's diseaseChristian Wider, Sarah J Lincoln, Michael G Heckman, et al.
American Journal of Neurodegenerative Disease|December 10, 2013
GWAS risk factors in Parkinson's disease: LRRK2 coding variation and genetic interaction with PARK16Alexandra I Soto-Ortolaza, Michael G Heckman, Catherine Labbé, et al.
Pageof 14